Literature DB >> 3122757

Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.

T Urano1, S Urano, F J Castellino.   

Abstract

It has recently been reported that the fluorogenic serine proteolytic active site titrant, 4-methyl-umbelliferyl-p-guanidinobenzoate (MUGB), cannot be employed in this capacity for tissue-type plasminogen activator (TPA) [Geiger, M., and Binder, B.R. (1987) Biochim. Biophys. Acta 912, 34-40]. Since this observation has such important ramifications in this area of research, we have studied the reaction of MUGB with recombinant (rec)TPA under a variety of experimental conditions and find that MUGB is indeed an effective titrant of rec-two chain TPA (recTCTPA) at 4 degrees, a condition under which the deacylation rate constant is diminished to the point that acylation can be readily observed. The KS for the interaction of MUGB with recTCTPA is 43 microM-46 microM, the acylation rate constant, k2, is approximately 3.6 min-1-4.2 min-1, and the rate constant for deacylation of p-guanidinobenzoyl-recTCTPA is 0.084 min-1-0.110 min-1. This same recTCTPA, after treatment with diisopropylfluorophosphate, does not react with MUGB. Single-chain TPA (recSCTPA) has been found to acylate more slowly than its two-chain counterpart and to exhibit a higher degree of turnover of the acyl-enzyme with this reagent. These results demonstrate that the active site concentration of TCTPA can be accurately determined by titration with MUGB, a consideration which is essential to the proper kinetic evaluation of this agent and its genetic variants. On the other hand, the presteady state kinetic characteristics for MUGB toward SCTPA are not favorable for its use as a titrant with this form of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3122757     DOI: 10.1016/0006-291x(88)90484-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.

Authors:  F S Steven; L A Williams; H Maier; J Arndt; H Weidauer; A Born
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.

Authors:  P J Gaffney; T Urano; V S de Serrano; M Mahmoud-Alexandroni; A R Metzger; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.

Authors:  A Vindigni; E Di Cera
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

4.  Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.

Authors:  V S de Serrano; T Urano; P J Gaffney; F J Castellino
Journal:  J Protein Chem       Date:  1989-02

5.  Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022.

Authors:  U Kohnert; M Wozny; M Llinas; A Roos; S Fischer
Journal:  Appl Biochem Biotechnol       Date:  1995-11       Impact factor: 2.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.